Understanding how the liver processes antisense oligonucleotides
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
This study is looking at how a special type of treatment called antisense oligonucleotides (ASOs) is processed in the liver, which could help make these treatments work better for people with certain diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Lincoln NIH-funded |
| Lab location | 1 site (Lincoln, United States) |
| Project ID | NIH-10889114 on NIH RePORTER |
What this research studies
This research investigates how antisense oligonucleotides (ASOs), which are short strands of genetic material, are metabolized in the liver. The study focuses on the role of specific receptors in the liver that help clear these ASOs from the bloodstream and how this process affects their ability to target and reduce gene expression. By examining the mechanisms of ASO uptake and clearance, the research aims to improve the effectiveness of ASO therapies for various diseases. Patients may benefit from a better understanding of how these treatments work and how to enhance their delivery to target tissues.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that could be treated with antisense oligonucleotide therapies.
Not a fit: Patients who do not have conditions amenable to treatment with antisense oligonucleotides may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective antisense oligonucleotide therapies for patients with genetic disorders or other conditions.
How similar studies have performed: Other research has shown promising results in understanding the metabolism of antisense oligonucleotides, but this specific approach is novel.
Where this research is happening
Lincoln, United States
- University of Nebraska Lincoln — Lincoln, United States (Active)
Researchers
- Principal investigator: Harris, Edward N — University of Nebraska Lincoln
- Study coordinator: Harris, Edward N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.